CBER Redirect Page
The regulatory responsibility, review and continuing oversight for many biologic therapeutic products has been transferred from the Center for Biologics Evaluation and Research (CBER) to the Center for Drug Evaluation and Research (CDER).
The information is now located at http://www.fda.gov/cder/biologics/default.htm